| Title | Modern treatment of acromegaly. | | Author(s) | Merza Z | | Institution | Endocrine and Diabetes Center, Northern General Hospital, Sheffield, UK. zmerza@aol.com | | Source | Postgrad Med J 2003 Apr; 79(930):189-93; quiz 192-4. | | MeSH | Acromegaly
Dopamine Agonists
Humans
Radiosurgery
Receptors, Somatotropin
Somatostatin
| | Abstract | Acromegaly is an endocrine disorder characterised by increased morbidity and mortality. It is usually caused by a growth hormone secreting pituitary adenoma and is manifested by a variety of clinical features. Surgery is usually the treatment of choice, however over the last few years, several new methods of treatment have been developed. A recent consensus on the targets for treatment has led to multiple studies being conducted to assess the efficacy of the currently available options. This review examines the evidence for and against these treatments. | | Language | eng | | Pub Type(s) | Journal Article
Review
| | PubMed ID | 12743333 |
|
